LY2109761, the TGF-β/smad pathway inhibitor, can reverse 5-FU-induced EMT and inhibit the expression of slug and nuclear translocation of Smad2 in NSCLC cells underwent EMT (Figure 4C, 4D). Here, SNAI2 is linked to non-small cell lung carcinoma.